Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozo Morimoto

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2020
Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung DiseaseKoji Furuuchi, Keiji Fujiwara, Fumiko Uesgi, et al.
Respiratory Medicine|September 29, 2023
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary diseaseMasashi Ito, Koji Furuuchi, Keiji Fujiwara, et al.
Respiratory Investigation|January 26, 2024
Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT studyKozo Morimoto, Mizu Nonaka, Yoshitaka Yamazaki, et al.
Respiratory Medicine|September 29, 2020
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimationJodie A Schildkraut, Jack Gallagher, Kozo Morimoto, et al.
ERJ Open Research|October 29, 2025
Gene expression profiling of airway epithelium in <i>Mycobacterium avium</i> complex lung diseaseKoji Furuuchi, Minako Hijikata, Shintaro Seto, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2023
<i>In Vitro</i> Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessusKeiji Fujiwara, Akio Aono, Takahiro Asami, et al.
Medicine|May 18, 2022
Analysis of risk factors for pulmonary tuberculosis with persistent severe inflammation: An observational studyMasafumi Shimoda, Takashi Yoshiyama, Masao Okumura, et al.
Respiratory Investigation|January 31, 2025
Association of poor sleep quality with clinical variables in nontuberculous mycobacterial pulmonary diseaseYuki Toyoda, Mitsuru Tabusadani, Yusuke Matsumura, et al.
Infection|February 2, 2022
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort studyFumiya Watanabe, Shota Kaburaki, Koji Furuuchi, et al.
Respiratory Medicine|June 19, 2024
Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatmentFumiya Watanabe, Keiji Fujiwara, Koji Furuuchi, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2020
Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung DiseaseKoji Furuuchi, Keiji Fujiwara, Fumiko Uesgi, et al.
Respiratory Medicine|September 29, 2023
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary diseaseMasashi Ito, Koji Furuuchi, Keiji Fujiwara, et al.
Respiratory Investigation|January 26, 2024
Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT studyKozo Morimoto, Mizu Nonaka, Yoshitaka Yamazaki, et al.
Respiratory Medicine|September 29, 2020
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimationJodie A Schildkraut, Jack Gallagher, Kozo Morimoto, et al.
ERJ Open Research|October 29, 2025
Gene expression profiling of airway epithelium in <i>Mycobacterium avium</i> complex lung diseaseKoji Furuuchi, Minako Hijikata, Shintaro Seto, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2023
<i>In Vitro</i> Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessusKeiji Fujiwara, Akio Aono, Takahiro Asami, et al.
Medicine|May 18, 2022
Analysis of risk factors for pulmonary tuberculosis with persistent severe inflammation: An observational studyMasafumi Shimoda, Takashi Yoshiyama, Masao Okumura, et al.
Respiratory Investigation|January 31, 2025
Association of poor sleep quality with clinical variables in nontuberculous mycobacterial pulmonary diseaseYuki Toyoda, Mitsuru Tabusadani, Yusuke Matsumura, et al.
Infection|February 2, 2022
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort studyFumiya Watanabe, Shota Kaburaki, Koji Furuuchi, et al.
Respiratory Medicine|June 19, 2024
Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatmentFumiya Watanabe, Keiji Fujiwara, Koji Furuuchi, et al.
Pageof 20